CN110800904A - Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof - Google Patents
Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof Download PDFInfo
- Publication number
- CN110800904A CN110800904A CN201810886772.8A CN201810886772A CN110800904A CN 110800904 A CN110800904 A CN 110800904A CN 201810886772 A CN201810886772 A CN 201810886772A CN 110800904 A CN110800904 A CN 110800904A
- Authority
- CN
- China
- Prior art keywords
- powder
- solid beverage
- beverage composition
- raw materials
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 235000013361 beverage Nutrition 0.000 title claims abstract description 30
- 239000007787 solid Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title description 11
- 239000000843 powder Substances 0.000 claims abstract description 72
- 239000002994 raw material Substances 0.000 claims abstract description 30
- 244000269722 Thea sinensis Species 0.000 claims abstract description 19
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 19
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 19
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 17
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 17
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 17
- 235000021119 whey protein Nutrition 0.000 claims abstract description 17
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 16
- 229920001202 Inulin Polymers 0.000 claims abstract description 12
- 229940029339 inulin Drugs 0.000 claims abstract description 12
- 229940054810 white kidney bean extract Drugs 0.000 claims abstract description 12
- 235000021092 sugar substitutes Nutrition 0.000 claims abstract description 11
- 239000003765 sweetening agent Substances 0.000 claims abstract description 11
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 11
- JGFBQFKZKSSODQ-UHFFFAOYSA-N Isothiocyanatocyclopropane Chemical compound S=C=NC1CC1 JGFBQFKZKSSODQ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 108010084695 Pea Proteins Proteins 0.000 claims abstract description 9
- PWLNAUNEAKQYLH-UHFFFAOYSA-N butyric acid octyl ester Natural products CCCCCCCCOC(=O)CCC PWLNAUNEAKQYLH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000011575 calcium Substances 0.000 claims abstract description 9
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 9
- 235000012055 fruits and vegetables Nutrition 0.000 claims abstract description 9
- UUIQMZJEGPQKFD-UHFFFAOYSA-N n-butyric acid methyl ester Natural products CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019702 pea protein Nutrition 0.000 claims abstract description 9
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 9
- 235000013616 tea Nutrition 0.000 claims description 9
- 239000000811 xylitol Substances 0.000 claims description 9
- 235000010447 xylitol Nutrition 0.000 claims description 9
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 9
- 229960002675 xylitol Drugs 0.000 claims description 9
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 229940013618 stevioside Drugs 0.000 claims description 8
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 8
- 235000019202 steviosides Nutrition 0.000 claims description 8
- 235000009569 green tea Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 230000009467 reduction Effects 0.000 claims description 7
- 238000004260 weight control Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 6
- 244000099147 Ananas comosus Species 0.000 claims description 3
- 235000007119 Ananas comosus Nutrition 0.000 claims description 3
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 claims description 3
- 239000004386 Erythritol Substances 0.000 claims description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 3
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 3
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 3
- 239000004376 Sucralose Substances 0.000 claims description 3
- 229940069765 bean extract Drugs 0.000 claims description 3
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 claims description 3
- 244000013123 dwarf bean Species 0.000 claims description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 3
- 235000019414 erythritol Nutrition 0.000 claims description 3
- 229940009714 erythritol Drugs 0.000 claims description 3
- 235000021278 navy bean Nutrition 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 229960001462 sodium cyclamate Drugs 0.000 claims description 3
- 235000019408 sucralose Nutrition 0.000 claims description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 3
- 244000298697 Actinidia deliciosa Species 0.000 claims description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 2
- 235000000832 Ayote Nutrition 0.000 claims description 2
- 235000004936 Bromus mango Nutrition 0.000 claims description 2
- 244000060011 Cocos nucifera Species 0.000 claims description 2
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 2
- 240000004244 Cucurbita moschata Species 0.000 claims description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 2
- 240000009088 Fragaria x ananassa Species 0.000 claims description 2
- 244000017020 Ipomoea batatas Species 0.000 claims description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 2
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 235000014826 Mangifera indica Nutrition 0.000 claims description 2
- 235000009184 Spondias indica Nutrition 0.000 claims description 2
- 235000006468 Thea sinensis Nutrition 0.000 claims description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 235000020279 black tea Nutrition 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- 235000015136 pumpkin Nutrition 0.000 claims description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 claims 1
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 230000037221 weight management Effects 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 17
- 230000037396 body weight Effects 0.000 description 16
- 208000008589 Obesity Diseases 0.000 description 13
- 235000020824 obesity Nutrition 0.000 description 13
- 230000001276 controlling effect Effects 0.000 description 12
- 229940057917 medium chain triglycerides Drugs 0.000 description 12
- 230000000694 effects Effects 0.000 description 8
- 210000003205 muscle Anatomy 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 235000013325 dietary fiber Nutrition 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 241000186016 Bifidobacterium bifidum Species 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- 206010033307 Overweight Diseases 0.000 description 4
- WLJUMPWVUPNXMF-UHFFFAOYSA-L calcium;3-hydroxy-3-methylbutanoate Chemical compound [Ca+2].CC(C)(O)CC([O-])=O.CC(C)(O)CC([O-])=O WLJUMPWVUPNXMF-UHFFFAOYSA-L 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 201000008482 osteoarthritis Diseases 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 240000005561 Musa balbisiana Species 0.000 description 2
- 102000008934 Muscle Proteins Human genes 0.000 description 2
- 108010074084 Muscle Proteins Proteins 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000004129 fatty acid metabolism Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000037257 muscle growth Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 208000008425 Protein deficiency Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- YZHOZVWZUXBPMD-UHFFFAOYSA-N calcium;3-hydroxy-3-methylbutanoic acid Chemical compound [Ca].CC(C)(O)CC(O)=O YZHOZVWZUXBPMD-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000037080 exercise endurance Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000001705 insufficient nutrition Nutrition 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000020166 milkshake Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The embodiment of the invention discloses a solid beverage composition capable of effectively controlling weight and reducing fat, which is prepared from the following raw materials, by mass, 13.5-33.3% of inulin, 3.3-12.7% of fructo-oligosaccharide, 0-40% of whey protein powder, 0-29.6% of pea protein, 0-10.4% of white kidney bean extract, 0.6-5.5% of β -hydroxy- β -calcium methylbutyrate, 1.3-3% of L-carnitine, 0.6-19.3% of medium-chain triglyceride, 2-6.7% of fruit and vegetable powder or tea powder and 0.08-18.3% of sugar substitute.
Description
Technical Field
The invention relates to a milk protein-containing solid beverage or dietary fiber-containing solid beverage, belongs to the field of nutritional foods, and relates to a solid beverage composition for effectively controlling weight and reducing fat and a preparation method thereof.
Background
In 2016, China issued a compendium for the planning of "healthy China 2030", which indicates that the nation and the whole people pay more attention to health, in order to implement the compendium, there was issued a nutritional plan for the people (2017 and 2030), from which it can be seen that obesity has attracted much attention. The report on the condition of nutrition and chronic disease of Chinese residents in 2015 indicates that the overweight rate of adults aged 18 years and older in the country is 30.1 percent, the obesity rate is 11.9 percent, and the percentage is increased by 7.3 percent and 4.8 percent compared with that in 2002. The overweight rate and the obesity rate of the teenagers of the children of 6 to 17 years old are 9.6 percent and 6.4 percent respectively, which are 5.1 percent and 4.3 percent higher than the overweight rate of the teenagers of the children of 2002 year old. Obesity is a ubiquitous social problem and needs to be solved urgently.
For Chinese adults, the BMI is between 24.0 and 27.9 and is overweight; obesity is judged by a BMI of more than or equal to 28. The research result shows that: obesity has adverse health effects. The American cancer society proposes that the BMI of the American male and female with the lowest fatality rate is 22-25kg/m2. If BMI > 25kg/m2Or BMI < 20kg/m2The fatality rate will increase. Obesity increases the probability of developing hypertension, with the incidence of hypertension being 2-3 times higher in obese people than in non-obese people. Meta-analysis of 24 million people in China shows that BMI is more than or equal to 28kg/m2The prevalence of hypertension in the patient is BMI at 24kg/m23.3 times of the following. Increasing arteriosclerosis diseases such as angina pectoris, myocardial infarction, coronary heart disease, etc., and the higher the obesity degree is, the higher the incidence rate of the diseases is. Increasing the risk of diabetes, obesity is one of the important risk factors for developing diabetes (type 2). In the people with long-term obesity, the prevalence rate of diabetes is obviously increased and can be 4 times as high as that of the common people. Of the type 2 diabetics, 80% are obese. The balance between synthesis and transport of triglyceride is disordered in obese patients, and a large amount of triglyceride is accumulated in the liver, so that fatty liver, cholelithiasis and cholecystitis are formed, the prevalence rate of gallstones in obese patients is 4 times that of non-obese patients, and the risk of abdominal accumulation is higher. Obesity is often a risk factor for nonalcoholic fatty liver disease, and some people with severe obesity are reported to detect fatty liver, liver fibrosis, inflammation and cirrhosis. The osteoarticular diseases caused by obesity are mainly three types: osteoarthritis, diabetic osteoarthritis and gouty osteoarthritis. Obese persons are susceptible to cancer, and obesity is closely related to the development of certain cancers.
Although the weight control product forest population is currently on the market, the phenomena of single effect, insufficient nutrition, incapability of replacing meals or poor taste exist. Through search, the weight-reducing effect of the product with the patent number of CN 102106498B is realized only by dietary fiber and protein, and the addition of minerals can affect the brewing and mouthfeel of the product.
Disclosure of Invention
In order to solve the problems in the prior art, an object of an embodiment of the present invention is to provide a solid beverage composition for effectively controlling body weight and reducing fat, which helps to manage body weight from multiple dimensions, and the composition performs body weight control mainly through multiple ways of regulating intestinal tract, blocking starch digestion and absorption, reducing fat, increasing muscle, increasing satiety, and the like, and provides a plurality of high-quality proteins and natural dietary fibers, thereby achieving scientific and healthy body weight management. Solves the problems of single efficacy, unobvious effect, hungry diet, insufficient nutrients and the like of the traditional weight-reducing product, and fills the gap of the current market.
In order to achieve the above purpose, according to a first aspect of the embodiments of the present invention, there is provided a solid beverage composition for effective weight control and fat reduction, the composition is prepared from, by mass, 13.5% -33.3% of inulin, 3.3% -12.7% of fructo-oligosaccharide, 0-40% of whey protein powder, 0-29.6% of pea protein, 0-10.4% of navy bean extract, 0.6% -5.5% of β -hydroxy- β -calcium methylbutyrate, 1.3% -3% of L-carnitine, 0.6% -19.3% of medium chain triglyceride, 2% -6.7% of fruit and vegetable powder or tea powder, and 0.08% -18.3% of sugar substitute
Further, the sugar substitute is selected from one or more of xylitol, erythritol, sodium cyclamate, stevioside and sucralose.
Further, the fruit and vegetable powder or tea powder is selected from one or more of apple powder, pineapple powder, blueberry powder, strawberry powder, banana powder, coconut powder, mango powder, kiwi fruit powder, pumpkin powder, purple sweet potato powder, black tea powder, green tea powder, instant green tea powder and matcha powder.
Furthermore, the composition is prepared from the following raw materials, by mass, 24.5-33.3% of inulin, 5.3-10.2% of fructo-oligosaccharide, 25-35.3% of whey protein powder, 0-10% of pea protein, 1.5-6.7% of white kidney bean extract, 0.6-4.0% of β -hydroxy- β -calcium methylbutyrate, 2-3% of L-carnitine, 0.6-14.3% of medium-chain triglyceride, 2-6.2% of fruit and vegetable powder or tea powder and 0.1-18.3% of sugar substitute.
Furthermore, the composition is prepared from the following raw materials, by mass, 26.6-33.3% of inulin, 8.0-10.2% of fructo-oligosaccharide, 25.0-32.6% of whey protein powder, 1.5-3.5% of white kidney bean extract, 2.0-2.7% of β -hydroxy- β -calcium methylbutyrate, 2.7-3% of L-carnitine, 1.0-4.7% of medium chain triglyceride, 3.0-6.2% of fruit and vegetable powder or tea powder, and 1.2-18.3% of sugar substitute.
Further, the composition is prepared from the following raw materials, by mass, 30% of inulin, 10.2% of fructo-oligosaccharide, 25% of whey protein powder, 1.5% of white kidney bean extract, 2.3% of β -hydroxy- β -calcium methylbutyrate, 3.0% of L-carnitine, 3.5% of medium-chain triglyceride, 6.2% of matcha powder, 16.8% of xylitol and 1.5% of stevioside.
According to a second aspect of the embodiments of the present invention, there is provided a method for preparing the solid beverage composition for effective weight control and fat reduction, comprising mixing the above raw materials in proportion, and packaging.
Further, the method comprises the steps of:
1) weighing: weighing all the raw materials according to the proportion;
2) premixing: premixing sugar substitute and whey protein powder for 3-5 minutes each time, pulverizing, and sieving with 40 mesh sieve;
3) total mixing: mixing all the raw materials for 30-60 min, and packaging.
The function of the raw materials adopted in the embodiment of the invention is introduced as follows:
inulin: is a soluble dietary fiber, can not be digested and absorbed in oral cavity, stomach and small intestine, and can only be completely fermented and degraded by some beneficial bacteria (such as Bacillus bifidus) in intestinal tract, so as to increase the value of Bacillus bifidus, inhibit the growth of harmful bacteria and regulate intestinal function. Because it is not absorbed, it provides lower energy. Or the inulin can reduce the digestion and absorption of fat and cholesterol in food by increasing the viscosity of digestive tract chyme and finally discharge the fat and cholesterol out of the body through excrement, thereby achieving the purpose of losing weight.
Fructo-oligosaccharide: fructans with a lower degree of polymerization (DP ═ 2-9) are commonly referred to as fructooligosaccharides. The fructo-oligosaccharide exists in various plants, exists in foods such as banana, garlic, honey, onion, wheat and the like which are eaten daily, and is excellent water-soluble dietary fiber. Since fructo-oligosaccharide is not digested and absorbed, it can reach large intestine and be used by beneficial flora such as Bacillus bifidus, and is effective proliferation factor of Bacillus bifidus. The organic acid generated by the fructo-oligosaccharide after being utilized by the bifidobacterium can lower the pH value in the intestines, inhibit the growth of spoilage bacteria such as salmonella in the intestines, improve the environment of the intestines, reduce the generation of the spoilage products in the intestines, prevent constipation, improve the immunity of the organism and have good health care function for human bodies.
Whey protein powder: the leucine is an important raw material substance for synthesizing skeletal muscle protein, and the oxidative metabolite of the leucine can also inhibit the activity of proteolytic enzyme, reduce the decomposition of muscle protein, and the high-level leucine is taken in the diet, so that the organism can obtain more lean body tissues and less fat, and the leucine has the effect of promoting muscle growth.
Pea protein: peas belong to the legume plant, and are rich in various nutrients required by the human body, especially high-quality protein. Pea protein contains all the amino acids essential for human body and belongs to complete protein. Protein is the material basis of life and is three major components of human body. Protein deficiency can lead to retarded growth, low immunity, flabby skin and premature aging.
The white kidney bean extract can effectively inhibit the activity of amylase (α -amylase), is taken half an hour before meals, reduces the absorption of starch, blocks the conversion of starch into sugar, reduces the glycemic index (GI value), can control the body weight without diet or hunger, and keeps the blood sugar level.
β -hydroxy- β -methylbutanoic acid calcium (HMB) has effects in promoting muscle growth, reducing muscle loss, increasing fat consumption, increasing muscle, increasing basal metabolic rate of the body, and subsequently increasing energy expenditure.
L-carnitine: is an essential accessory factor of fatty acid metabolism and a basic substance for the fatty acid metabolism and energy acquisition of organisms, so that the L-carnitine is supplied before exercise, and the L-carnitine can promote the fat metabolism to provide energy for the organisms.
Medium Chain Triglycerides (MCT): triglycerides composed of medium-chain fatty acids (C8, C10) mainly caprylic triglyceride and capric triglyceride. Can be rapidly absorbed in duodenum and directly transported to liver through vein, which can rapidly oxidize function, enhance exercise endurance and reduce protein consumption; adipose tissue can be significantly reduced rather than muscle tissue.
Sugar substitution: there is a sweet taste of sugar but no high calories (or very low calories) of sugar.
The embodiment of the invention has the following advantages:
1. the solid beverage composition provided by the embodiment of the invention is mainly used for controlling the body weight through multiple ways of regulating intestinal tracts, blocking starch digestion and absorption, reducing fat, increasing muscle, increasing satiety and the like, and simultaneously provides high-quality protein and natural dietary fiber, so that the body weight can be scientifically and healthily managed, and the solid beverage composition is free from rebound, safe, free from side effects and free from damage to the body.
2. The preparation method disclosed by the embodiment of the invention has the advantages of simple process and strong operability, and can be used for mass production.
Detailed Description
The raw materials used in the following examples are inulin (No. 5 of Ministry of health, 2009), fructo-oligosaccharide (GB/T23528-.
Example 1
The raw material ratio of the solid beverage composition for effectively controlling body weight and reducing fat in this example is shown in table 1.
TABLE 1
The preparation method of the composition comprises the following steps:
1) weighing: weighing all the raw materials according to the proportion;
2) premixing: premixing erythritol and whey protein powder for 3-5 minutes each time, pulverizing for three times, and sieving with 40 mesh sieve;
3) total mixing: mixing all the raw materials for 30-60 min to obtain solid beverage composition effective in controlling body weight and reducing fat.
The obtained solid beverage composition for effectively controlling body weight and reducing fat is subpackaged according to 15 g/bar.
Example 2
The raw material ratio of the solid beverage composition for effectively controlling body weight and reducing fat in this example is shown in table 2.
TABLE 2
Name of raw materials | Dosage (kg) |
Inulin powder | 22.0 |
Fructo-oligosaccharide | 3.3 |
Whey protein powder | 26.7 |
Pea protein | 17.0 |
White kidney bean extract | 10.4 |
β -hydroxy- β -methylbutyrate calcium (HMB) | 3.30 |
L-carnitine | 1.30 |
Medium Chain Triglycerides (MCT) | 5.0 |
Strawberry powder | 5.3 |
Xylitol, its preparation method and use | 0.62 |
Sodium cyclamate | 5.00 |
Sucralose | 0.08 |
The composition was prepared as in example 1.
Example 3
The raw material ratio of the solid beverage composition for effectively controlling body weight and reducing fat in this example is shown in table 3.
TABLE 3
Name of raw materials | Dosage (kg) |
Inulin powder | 24.5 |
Fructo-oligosaccharide | 5.3 |
Pea protein | 29.6 |
White kidney bean extract | 6.7 |
β -hydroxy- β -methylbutyrate calcium (HMB) | 2.0 |
L-carnitine | 2.0 |
Medium Chain Triglycerides (MCT) | 19.3 |
Pineapple powder | 4.0 |
Xylitol, its preparation method and use | 6.5 |
Stevioside | 0.1 |
The composition was prepared as in example 1.
Example 4
The raw material ratio of the solid beverage composition for effectively controlling body weight and reducing fat in this example is shown in table 4.
TABLE 4
The composition was prepared as in example 1.
Example 5
The raw material ratio of the solid beverage composition for effectively controlling body weight and reducing fat in this example is shown in table 5.
TABLE 5
Name of raw materials | Dosage (kg) |
Inulin powder | 33.3 |
Fructo-oligosaccharide | 8.0 |
Whey protein powder | 32.6 |
White kidney bean extract | 2.7 |
β -hydroxy- β -methylbutyrate calcium (HMB) | 2.7 |
Levogyration meatAlkali | 2.7 |
Medium Chain Triglycerides (MCT) | 0.6 |
Green tea powder | 3.33 |
Xylitol, its preparation method and use | 13.33 |
Stevioside | 0.8 |
The composition was prepared as in example 1.
Example 6
The raw material ratio of the solid beverage composition for effectively controlling body weight and reducing fat in this example is shown in table 6.
TABLE 6
The composition was prepared as in example 1.
Example 7
The raw material composition of a solid beverage composition for effective weight control and fat reduction of this example is shown in table 7.
TABLE 7
Name of raw materials | Dosage (kg) |
Inulin powder | 30.0 |
Fructo-oligosaccharide | 10.2 |
Whey protein powder | 25.0 |
White kidney bean extract | 1.5 |
β -hydroxy- β -methylbutyrate calcium (HMB) | 2.3 |
L-carnitine | 3.0 |
Medium Chain Triglycerides (MCT) | 3.5 |
Green tea powder | 6.2 |
Xylitol, its preparation method and use | 16.8 |
Stevioside | 1.5 |
The composition was prepared as in example 1.
Experimental example 1
By adopting a comprehensive scoring method, 10 professionals are asked to evaluate all sensory indexes of color, organization state, brewing property, taste and smell of the product, the average value is taken as a final score, 10 sensory evaluation standards are shown in a table 8, and the total score is 100.
TABLE 8
A commercial protein milkshake (control 1), a protein dietary fiber powder (control 2) and compositions 1 to 7 prepared in examples 1 to 7 of the present invention were subjected to sensory evaluation with reference to the scoring criteria in Table 8, and the results are shown in Table 9
TABLE 9
Sample (I) | Color and luster | Tissue state | Reconstitution property | Taste and smell | Total score |
Control 1 | 13.63±5.97 | 11.10±4.87 | 25.63±6.18 | 32.13±5.22 | 82.49±12.32 |
Control 2 | 13.73±5.21 | 10.43±4.27 | 22.33±6.94 | 30.37±4.88 | 76.86±11.85 |
Composition 1 | 14.27±3.98 | 13.27±3.22 | 27.50±4.33 | 36.23±4.56 | 91.27±8.33 |
Composition 2 | 14.80±3.59 | 13.68±3.74 | 27.47±4.58 | 36.33±4.11 | 92.28±8.36 |
Composition 3 | 13.97±3.28 | 13.83±3.26 | 27.53±3.77 | 37.47±3.78 | 92.80±7.74 |
Composition 4 | 14.13±2.54 | 14.27±2.76 | 28.73±3.26 | 37.73±4.56 | 94.86±7.16 |
Composition 5 | 14.37±3.25 | 14.50±3.35 | 28.80±3.54 | 37.93±3.97 | 95.60±6.41 |
Composition 6 | 14.27±2.78 | 14.63±2.11 | 29.00±3.78 | 38.40±3.20 | 96.30±6.78 |
Composition 7 | 14.13±2.14 | 14.27±1.80 | 29.33±2.78 | 38.57±3.01 | 96.27±5.89 |
The solid beverage composition provided by the embodiment of the invention has uniform and consistent color and no visible foreign impurities; the tissue form is powder without agglomeration; has good mixing property, special taste and no peculiar smell. The sensory evaluation result is superior to the selected control sample on the market, and the mouthfeel is better.
Experimental example 2: human body efficacy test
1. Test sample
The solid beverage compositions of examples 1-7 of the present invention were used as test samples, and the raw material ratios of control group 1 are shown in table 10, and the preparation methods thereof are similar to the methods disclosed in the examples of the present invention.
Watch 10
Name of raw materials | Dosage (kg) |
Inulin powder | 30.0 |
Fructo-oligosaccharide | 10.2 |
Whey protein powder | 25.0 |
White kidney bean extract | 1.5 |
L-carnitine | 3.0 |
Green tea powder | 6.2 |
Xylitol, its preparation method and use | 16.8 |
Maltodextrin | 5.8 |
Stevioside | 1.5 |
2. Screening of test population
440 volunteers who voluntarily receive the test feeding test are selected as study objects, all volunteers have BMI of 23, are 110 male and female respectively, have the age range of 18-60 years, and are randomly divided into a test group (n-385) and a control group (n-55) according to the subjects according to the principle of random double-blindness, wherein the test groups respectively test feed 1-7 compositions for 55 persons; the comparison of the basic data such as sex, age, diet, and exercise status of two groups of people has no statistical significance (P >0.05), and has comparability.
3. Test method
The subjects were subjected to a 36-day human test using self-control and inter-group control, with the test groups receiving the compositions of examples 1-7 and the control group receiving the control. The eating times, the consumption and the time are as follows: the powder is taken after being mixed with water half an hour before a meal, three times a day, 15g each time.
The physical indexes are detected every nine days as a period.
4. Data statistics
The data were processed with Excel and the test data were statistically analyzed using the t-test, with P >0.05 considered no significant difference, P < 0.05 considered significant difference and P < 0.01 considered very significant difference.
5. Results
The statistical results of the human feeding test results are shown in Table 11.
TABLE 11
Note: indicates that the corresponding cycle after consumption has significant difference compared with before consumption; indicates that the corresponding cycle after consumption had a very significant difference compared to before consumption.
# indicates that the test group had significant differences from the control group at the same cycle; # indicates that the test group had a very significant difference from the control group in the same cycle.
As can be seen from Table 11, after 2 weeks of eating, the test groups showed significant differences in weight loss compared to the control group, after 2-3 weeks of eating, the test groups showed significant differences in percent body fat loss compared to the control group, and after 4 weeks of eating, the results showed significant synergistic effects of fat reduction and muscle enhancement by adding β -hydroxy- β -methylcalcium butyrate (HMB) and Medium Chain Triglycerides (MCT) to the inventive examples.
6. Conclusion
The product disclosed by the embodiment of the invention has stronger satiety, helps a subject to reduce food intake, inhibits starch absorption, promotes muscle synthesis and fat decomposition of the body, ensures that the body weight can be reduced, reduces the body fat percentage and increases the muscle proportion. And the tea is safe, has no side effect, cannot cause harm to the body, and has better mouthfeel.
Although the invention has been described in detail above with reference to a general description and specific examples, it will be apparent to one skilled in the art that modifications or improvements may be made thereto based on the invention. Accordingly, such modifications and improvements are intended to be within the scope of the invention as claimed.
Claims (8)
1. The solid beverage composition is characterized by being prepared from the following raw materials, by mass, 13.5% -33.3% of inulin, 3.3% -12.7% of fructo-oligosaccharide, 0-40% of whey protein powder, 0-29.6% of pea protein, 0-10.4% of navy bean extract, 0.6% -5.5% of β -hydroxy- β -calcium methylbutyrate, 1.3% -3% of L-carnitine, 0.6% -19.3% of medium-chain triglyceride, 2% -6.7% of fruit and vegetable powder or tea powder and 0.08% -18.3% of sugar substitute.
2. The solid beverage composition for effective weight control and fat reduction according to claim 1, wherein the sugar substitute is one or more selected from the group consisting of xylitol, erythritol, sodium cyclamate, stevioside, and sucralose.
3. The solid beverage composition for controlling weight and reducing fat effectively as claimed in claim 1 or 2, wherein the fruit and vegetable powder or tea powder is selected from one or more of apple powder, pineapple powder, blueberry powder, strawberry powder, banana powder, coconut powder, mango powder, kiwi powder, pumpkin powder, purple sweet potato powder, black tea powder, green tea powder, instant green tea powder and matcha powder.
4. The solid beverage composition capable of effectively controlling weight and reducing fat according to claim 3, wherein the composition is prepared from, by mass, 24.5% -33.3% of inulin, 5.3% -10.2% of fructo-oligosaccharide, 25% -35.3% of whey protein powder, 0-10% of pea protein, 1.5% -6.7% of white kidney bean extract, 0.6% -4.0% of β -hydroxy- β -calcium methylbutyrate, 2% -3% of L-carnitine, 0.6% -14.3% of medium-chain triglyceride, 2% -6.2% of fruit and vegetable powder or tea powder, and 0.1% -18.3% of sugar substitute.
5. The solid beverage composition for effectively controlling weight and reducing fat according to claim 3, wherein the composition is prepared from, by mass, 26.6% -33.3% of inulin, 8.0-10.2% of fructo-oligosaccharide, 25.0-32.6% of whey protein powder, 1.5-3.5% of navy bean extract, 2.0-2.7% of β -hydroxy- β -calcium methylbutyrate, 2.7% -3% of L-carnitine, 1.0-4.7% of medium chain triglyceride, 3.0-6.2% of fruit and vegetable powder or tea powder, and 1.2-18.3% of sugar substitute.
6. The solid beverage composition capable of effectively controlling weight and reducing fat according to claim 3, wherein the composition is prepared from the following raw materials, by mass, 30% of inulin, 10.2% of fructo-oligosaccharide, 25% of whey protein powder, 1.5% of white kidney bean extract, 2.3% of β -hydroxy- β -calcium methylbutyrate, 3.0% of L-carnitine, 3.5% of medium-chain triglyceride, 6.2% of powdered matcha, 16.8% of xylitol and 1.5% of stevioside.
7. A method of preparing the solid beverage composition effective in weight control and fat reduction according to claim 1, wherein the raw materials are mixed in a ratio and packaged.
8. The method of preparing a solid beverage composition effective for weight management and fat reduction as claimed in claim 7, wherein the method comprises the steps of:
1) weighing: weighing all the raw materials according to the proportion;
2) premixing: premixing sugar substitute and whey protein powder for 3-5 minutes each time, pulverizing, and sieving with 40 mesh sieve;
3) total mixing: mixing all the raw materials for 30-60 min, and packaging.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810886772.8A CN110800904A (en) | 2018-08-06 | 2018-08-06 | Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810886772.8A CN110800904A (en) | 2018-08-06 | 2018-08-06 | Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110800904A true CN110800904A (en) | 2020-02-18 |
Family
ID=69487296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810886772.8A Pending CN110800904A (en) | 2018-08-06 | 2018-08-06 | Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110800904A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111418655A (en) * | 2020-03-26 | 2020-07-17 | 浙江康伽蒂健康科技有限公司 | Protein type solid beverage with fat reducing and body shaping effects |
CN111493326A (en) * | 2020-04-28 | 2020-08-07 | 成都尚医信息科技有限公司 | Enteral nutrition food and preparation method and application thereof |
WO2020193291A1 (en) * | 2019-03-22 | 2020-10-01 | Société des Produits Nestlé S.A. | Methods using administration of medium chain triglycerides (mct) prior to a meal to increase ketone production from the mcts |
CN111972672A (en) * | 2020-08-25 | 2020-11-24 | 黑龙江省完达山乳业股份有限公司 | Composition with muscle increasing function and application thereof |
CN112189796A (en) * | 2020-09-11 | 2021-01-08 | 杭州娃哈哈集团有限公司 | Vegetable protein beverage with clean label and preparation method thereof |
CN112931743A (en) * | 2021-04-12 | 2021-06-11 | 南京乔康生物科技有限公司 | Solid beverage beneficial to body shaping and preparation method thereof |
CN114145377A (en) * | 2021-09-30 | 2022-03-08 | 南阳市瑞佳食品有限公司 | Sugar-free tablet candy and preparation method thereof |
CN114158641A (en) * | 2021-09-30 | 2022-03-11 | 南阳市瑞佳食品有限公司 | Sugar-free hard candy and preparation method thereof |
CN114304461A (en) * | 2021-12-30 | 2022-04-12 | 四川光友薯业有限公司 | Anthocyanin functional solid beverage and preparation method thereof |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104287049A (en) * | 2014-11-07 | 2015-01-21 | 江苏艾兰得营养品有限公司 | Meal replacement protein powder solid beverage for managing body weight |
CN104780786A (en) * | 2012-09-21 | 2015-07-15 | 雅培制药有限公司 | Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes |
WO2015105981A2 (en) * | 2014-01-09 | 2015-07-16 | Abbott Laboratories | Conditional essentiality of hmb |
CN105285983A (en) * | 2015-10-27 | 2016-02-03 | 江西美庐乳业集团有限公司 | Weight losing and slimming nutrition package |
US20160128372A1 (en) * | 2013-06-10 | 2016-05-12 | N.V. Nutricia | Muscle preservation in overweight or obese adult during weight loss program |
CN106136247A (en) * | 2016-07-01 | 2016-11-23 | 北京斯利安药业有限公司 | A kind of Semen Phaseoli Vulgaris many certain kind of berries compositions and preparation method thereof |
CN106387586A (en) * | 2016-08-31 | 2017-02-15 | 宣城柏维力生物工程有限公司 | Whey protein and beta-hydroxy-methyl butyrate sport drink and production technology thereof |
CN106509126A (en) * | 2016-10-25 | 2017-03-22 | 郑州福润德食品有限公司 | Solid drink having weight losing and body slimming functions |
CN108142927A (en) * | 2017-12-25 | 2018-06-12 | 诺和生物技术(天津)有限公司 | It is a kind of to be used to meet composition of motion control weight demand and preparation method thereof |
-
2018
- 2018-08-06 CN CN201810886772.8A patent/CN110800904A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104780786A (en) * | 2012-09-21 | 2015-07-15 | 雅培制药有限公司 | Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes |
US20160128372A1 (en) * | 2013-06-10 | 2016-05-12 | N.V. Nutricia | Muscle preservation in overweight or obese adult during weight loss program |
WO2015105981A2 (en) * | 2014-01-09 | 2015-07-16 | Abbott Laboratories | Conditional essentiality of hmb |
CN104287049A (en) * | 2014-11-07 | 2015-01-21 | 江苏艾兰得营养品有限公司 | Meal replacement protein powder solid beverage for managing body weight |
CN105285983A (en) * | 2015-10-27 | 2016-02-03 | 江西美庐乳业集团有限公司 | Weight losing and slimming nutrition package |
CN106136247A (en) * | 2016-07-01 | 2016-11-23 | 北京斯利安药业有限公司 | A kind of Semen Phaseoli Vulgaris many certain kind of berries compositions and preparation method thereof |
CN106387586A (en) * | 2016-08-31 | 2017-02-15 | 宣城柏维力生物工程有限公司 | Whey protein and beta-hydroxy-methyl butyrate sport drink and production technology thereof |
CN106509126A (en) * | 2016-10-25 | 2017-03-22 | 郑州福润德食品有限公司 | Solid drink having weight losing and body slimming functions |
CN108142927A (en) * | 2017-12-25 | 2018-06-12 | 诺和生物技术(天津)有限公司 | It is a kind of to be used to meet composition of motion control weight demand and preparation method thereof |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020193291A1 (en) * | 2019-03-22 | 2020-10-01 | Société des Produits Nestlé S.A. | Methods using administration of medium chain triglycerides (mct) prior to a meal to increase ketone production from the mcts |
CN111418655A (en) * | 2020-03-26 | 2020-07-17 | 浙江康伽蒂健康科技有限公司 | Protein type solid beverage with fat reducing and body shaping effects |
CN111493326A (en) * | 2020-04-28 | 2020-08-07 | 成都尚医信息科技有限公司 | Enteral nutrition food and preparation method and application thereof |
CN111972672A (en) * | 2020-08-25 | 2020-11-24 | 黑龙江省完达山乳业股份有限公司 | Composition with muscle increasing function and application thereof |
CN112189796A (en) * | 2020-09-11 | 2021-01-08 | 杭州娃哈哈集团有限公司 | Vegetable protein beverage with clean label and preparation method thereof |
CN112931743A (en) * | 2021-04-12 | 2021-06-11 | 南京乔康生物科技有限公司 | Solid beverage beneficial to body shaping and preparation method thereof |
CN114145377A (en) * | 2021-09-30 | 2022-03-08 | 南阳市瑞佳食品有限公司 | Sugar-free tablet candy and preparation method thereof |
CN114158641A (en) * | 2021-09-30 | 2022-03-11 | 南阳市瑞佳食品有限公司 | Sugar-free hard candy and preparation method thereof |
CN114304461A (en) * | 2021-12-30 | 2022-04-12 | 四川光友薯业有限公司 | Anthocyanin functional solid beverage and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110800904A (en) | Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof | |
CN108835628B (en) | Weight-losing meal replacement powder and preparation method thereof | |
CN110663872A (en) | Full-nutrient meal replacement weight-losing food, preparation method and eating method | |
KR101107848B1 (en) | Functional noodle for aged people and manufacturing method thereof | |
CN111066847A (en) | Low GI (glycemic index) moon cake suitable for diabetics and preparation method thereof | |
CN107347958A (en) | A kind of quinoa biscuit | |
CN110973613A (en) | Plant composite powder composition suitable for weight-losing crowd, product suitable for weight-losing crowd and application | |
CN108391785A (en) | A kind of functionality meal replacement powder and its manufacture craft and application | |
CN107996975A (en) | A kind of quinoa weight losing meal-replacing powder containing burdock polysaccharide | |
CN110464010A (en) | A kind of weight-reducing cereal meal replacement powder | |
CN114376235A (en) | Weight-reducing probiotics and prebiotics composition beneficial to controlling in vivo fat and preparation method thereof | |
KR101722481B1 (en) | functional cereal containing sweet potato chip, broccoli granule and dietary fiber for constipation improving and manufacturing method thereof | |
US20140335123A1 (en) | Food Composition and Uses for Diabetes | |
CN110801005A (en) | Total nutrient cereal blending powder and preparation method thereof | |
CN111436606A (en) | Berry composite weight-losing meal replacement powder and preparation method thereof | |
CN110574862A (en) | Nutritional weight-losing meal replacement powder suitable for teenagers and children and preparation method thereof | |
CN102438469A (en) | Food complex for balancing masculine energy and feminine energy and for recovering vital energy | |
CN112136894A (en) | Nutritional dietary supplement food beneficial to cardiovascular health and preparation method and application thereof | |
CN1224339C (en) | Functional food and its use | |
CN107047692A (en) | A kind of functional compressive biscuit of the edible easy defecation of suitable army | |
KR100503208B1 (en) | Diet-food composition | |
CN108935576A (en) | A kind of nutritional meal replacing food and preparation method thereof | |
CN104687118A (en) | Nutritional fat-reducing instant powder | |
CN112106979A (en) | Prebiotics fruit and vegetable nutritional vermicelli as well as preparation method and application thereof | |
CN111165816A (en) | Weight-losing meal replacement powder for relaxing bowels and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200218 |
|
RJ01 | Rejection of invention patent application after publication |